Human cellular model for investigating cortico-striatal-midbrain neural pathways
Inventors
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Assignees
Leland Stanford Junior University
MemberStanford UniversityStanford UniversityTodd Coleman is an associate professor of bioengineering at Stanford University. His research combines applied probability, physiology, and bioelectronics to develop methods and devices for monitoring and modulating nervous-system and other physiological activity, including brain and visceral-organ signals.
Todd Coleman is an associate professor of bioengineering at Stanford University. His research combines applied probability, physiology, and bioelectronics to develop methods and devices for monitoring and modulating nervous-system and other physiological activity, including brain and visceral-organ signals.
Abstract
Human striatal and midbrain organoids or spheroids are generated in vitro, which may be generated at least in part from human pluripotent stem (hPS) cells. Such spheroids model the regions of the human brain and comprise specific sets of cells that are associated with the striatum, including mature medium spiny neurons, and midbrain of a human, and that can be subsequently assembled with the cortex to form cortico-striatal-midbrain circuits in vitro.
Core Innovation
The invention describes a midbrain-striatal assembloid formed from human pluripotent stem cell-derived midbrain and striatal spheroids. The spheroids are cultured in direct contact, and the resulting assembloid comprises human midbrain neurons projecting from the midbrain spheroid into the striatal spheroid. The described model brings these neural populations together in a human in vitro system.
The background section is not included in the provided partial content, so the problem being solved is not explicitly described in patent. The partial content proposes the midbrain-striatal assembloid for studying neural-circuit development and disease and for screening candidate treatments. It also reports characterization of midbrain dopaminergic cell populations and projection formation into the striatal spheroid.
Claims Coverage
The provided claims identify one independent claim. It covers producing a midbrain-striatal assembloid from separately generated midbrain and striatal spheroids and bringing them into direct contact to form projections between the spheroids.
Midbrain-striatal assembloid formation
The method produces human midbrain and striatal spheroids from human pluripotent stem cells and cultures the spheroids in direct contact, such that human midbrain neurons project from the midbrain spheroid into the striatal spheroid.
The independent claim covers the formation of a human midbrain-striatal assembloid with midbrain neuron projections into a striatal spheroid.
Stated Advantages
Not explicitly described in patent.
Documented Applications
Studying neural-circuit development and disease.
Screening candidate treatments.
Interested in licensing this patent?